{
    "2021-06-29": [
        [
            {
                "time": "",
                "original_text": "贝达药业(300558.SZ)股东凯铭投资质押500万股",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "凯铭投资",
                        "质押",
                        "500万股"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：凯铭投资累计质押2720万股，贝成投资累计质押150万股",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "凯铭投资",
                        "贝成投资",
                        "累计质押",
                        "2720万股",
                        "150万股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：药品临床试验申请获国家药监局受理",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "药品",
                        "临床试验",
                        "国家药监局",
                        "受理"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业(300558.SZ)：BPI-23314药品临床试验申请获得受理",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "BPI-23314",
                        "药品",
                        "临床试验",
                        "受理"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：治疗恶性血液系统肿瘤药品临床试验获NMPA受理",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "恶性血液系统肿瘤",
                        "药品",
                        "临床试验",
                        "NMPA",
                        "受理"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}